Namuhla, i-FDA yase-US imemezele ukugunyazwa komuthi omusha we-SIGA Technologies i-TPOXX (tecovirimat) wokwelapha ingxibongo. Kuhle ukusho ukuthi lona umuthi omusha wama-21 ogunyazwe yi-US FDA kulo nyaka kanye nomuthi omusha wokuqala ogunyazwe ukwelapha ingxibongo.
Igama lengxibongo, abafundi bemboni yezokwelapha ngeke babe abangalazi. Umuthi wokugoma ingxibongo uwumgomo wokuqala owenziwe ngempumelelo ngabantu, futhi sinesikhali sokuvikela lesi sifo esibulalayo. Kusukela ekugonyweni kwemithi yokugomela ingxibongo, abantu baye banqoba empini yokulwa namagciwane. Ngo-1980, i-World Health Organization yamemezela ukuthi sesiluqedile usongo lwengxibongo. Lolu hlobo lwesifo esithathelwanayo, esiye sathinteka kakhulu futhi osekukhulunywe ngaso, kancane kancane siye sashabalala emibonweni yabantu.
Kodwa ngenxa yobunkimbinkimbi besimo samazwe ngamazwe kula mashumi eminyaka, abantu baqala ukukhathazeka ngokuthi leli gciwane lengxibongo lingase lenziwe libe izikhali eziphilayo, ezisongela ukuphila kwabantu abavamile. Ngakho-ke, abantu baphinde banquma ukwenza umuthi okwazi ukwelapha ingxibongo esimweni esiphuthumayo. I-TPOXX yaba khona. Njengomuthi we-antiviral, ungakhomba ngempumelelo ukusabalala kwegciwane le-variola emzimbeni. Ngokusekelwe emandleni awo, lo muthi omusha unikezwe iziqu ezisheshayo, iziqu zokubuyekezwa okubalulekile, kanye neziqu zomuthi wezintandane.
Ukusebenza nokuphepha kwalo muthi omusha uhlolwe ezivivinyweni zezilwane nezabantu, ngokulandelana. Ekuhlolweni kwezilwane, izilwane ezitheleleke nge-TPOXX zaphila isikhathi eside kunalezo eziphathwe nge-placebo ngemva kokutheleleka ngegciwane le-variola. Ezivivinyweni zabantu, abacwaningi baqasha amavolontiya anempilo angama-359 (ngaphandle kokutheleleka ngengxibongo) futhi babacela ukuthi basebenzise i-TPOXX. Ucwaningo luye lwabonisa ukuthi imiphumela emibi ejwayelekile kakhulu yikhanda, isicanucanu, nobuhlungu besisu ngaphandle kwemiphumela emibi kakhulu. Ngokusekelwe ekusebenzeni okubonisiwe ekuhlolweni kwezilwane kanye nokuphepha okuboniswa ukuhlolwa kwabantu, i-FDA igunyaze ukwethulwa komuthi omusha.
"Ekuphenduleni ingozi ye-bioterrorism, iCongress ithathe izinyathelo zokuqinisekisa ukuthi amagciwane asetshenziswa njengezikhali, futhi senze futhi sagunyaza izinyathelo zokuphikisa. Ukugunyazwa kwanamuhla kubonisa ingqopha-mlando kule mizamo!” Umqondisi we-FDA uScott Gottlieb Udokotela uthe: “Lona umuthi wokuqala omusha ozonikezwa ukubuyekezwa okubalulekile kwe-'Material Threat Medical Countermeasure'. Ukugunyazwa kwanamuhla futhi kukhombisa ukuzibophezela kwe-FDA ekuqinisekiseni ukuthi siyilungele inkinga yezempilo yomphakathi futhi sinikeze ukuvikeleka okufika ngesikhathi. Imikhiqizo emisha yezidakamizwa esebenzayo.”
Nakuba lo muthi omusha kulindeleke ukuthi welaphe ingxibongo, sisalindele ukuthi ingxibongo ngeke iphinde ibuye, futhi sibheke ngabomvu usuku lapho abantu bengasoze bawusebenzisa lo muthi omusha.
Isikhathi sokuthumela: Jul-17-2018
